ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.

IMPORTANCE The role of ω-3 polyunsaturated fatty acids for primary prevention of coronary heart disease (CHD) remains controversial. Most prior longitudinal studies evaluated self-reported consumption rather than biomarkers. OBJECTIVE To evaluate biomarkers of seafood-derived eicosapentaenoic acid (EPA; 20:5ω-3), docosapentaenoic acid (DPA; 22:5ω-3), and docosahexaenoic acid (DHA; 22:6ω-3) and plant-derived α-linolenic acid (ALA; 18:3ω-3) for incident CHD. DATA SOURCES A global consortium of 19 studies identified by November 2014. STUDY SELECTION Available prospective (cohort, nested case-control) or retrospective studies with circulating or tissue ω-3 biomarkers and ascertained CHD. DATA EXTRACTION AND SYNTHESIS Each study conducted standardized, individual-level analysis using harmonized models, exposures, outcomes, and covariates. Findings were centrally pooled using random-effects meta-analysis. Heterogeneity was examined by age, sex, race, diabetes, statins, aspirin, ω-6 levels, and FADS desaturase genes. MAIN OUTCOMES AND MEASURES Incident total CHD, fatal CHD, and nonfatal myocardial infarction (MI). RESULTS The 19 studies comprised 16 countries, 45 637 unique individuals, and 7973 total CHD, 2781 fatal CHD, and 7157 nonfatal MI events, with ω-3 measures in total plasma, phospholipids, cholesterol esters, and adipose tissue. Median age at baseline was 59 years (range, 18-97 years), and 28 660 (62.8%) were male. In continuous (per 1-SD increase) multivariable-adjusted analyses, the ω-3 biomarkers ALA, DPA, and DHA were associated with a lower risk of fatal CHD, with relative risks (RRs) of 0.91 (95% CI, 0.84-0.98) for ALA, 0.90 (95% CI, 0.85-0.96) for DPA, and 0.90 (95% CI, 0.84-0.96) for DHA. Although DPA was associated with a lower risk of total CHD (RR, 0.94; 95% CI, 0.90-0.99), ALA (RR, 1.00; 95% CI, 0.95-1.05), EPA (RR, 0.94; 95% CI, 0.87-1.02), and DHA (RR, 0.95; 95% CI, 0.91-1.00) were not. Significant associations with nonfatal MI were not evident. Associations appeared generally stronger in phospholipids and total plasma. Restricted cubic splines did not identify evidence of nonlinearity in dose responses. CONCLUSIONS AND RELEVANCE On the basis of available studies of free-living populations globally, biomarker concentrations of seafood and plant-derived ω-3 fatty acids are associated with a modestly lower incidence of fatal CHD.

[1]  Simon G Thompson,et al.  Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. , 2014, Annals of internal medicine.

[2]  D. Mozaffarian,et al.  ω-3 Fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle , 2014, Heart.

[3]  D. Mozaffarian,et al.  Plasma Phospholipid Long-Chain-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults A Cohort Study , 2013 .

[4]  An Pan,et al.  α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. , 2012, The American journal of clinical nutrition.

[5]  E. Ntzani,et al.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.

[6]  Yuanqing Fu,et al.  Marine N-3 Polyunsaturated Fatty Acids Are Inversely Associated with Risk of Type 2 Diabetes in Asians: A Systematic Review and Meta-Analysis , 2012, PloS one.

[7]  D. Mozaffarian,et al.  Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis , 2012, British Journal of Nutrition.

[8]  H. Seo,et al.  Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. , 2012, Archives of internal medicine.

[9]  A. Wolk,et al.  Fish Consumption, Dietary Long-Chain n-3 Fatty Acids, and Risk of Type 2 Diabetes , 2012, Diabetes Care.

[10]  D. Mozaffarian,et al.  (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? , 2012, The Journal of nutrition.

[11]  T. Trikalinos,et al.  Effects of Eicosapentanoic Acid and Docosahexanoic Acid on Mortality Across Diverse Settings: Systematic Review and Meta-Analysis of Randomized Trials and Prospective Cohorts , 2012 .

[12]  D. Mozaffarian,et al.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.

[13]  Duo Li,et al.  Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies , 2011, Public Health Nutrition.

[14]  Peter C. Austin,et al.  Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk , 2011, Diabetes Care.

[15]  M. Fornage,et al.  Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium , 2011, PLoS genetics.

[16]  C. Serhan.  Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? , 2010, The American journal of pathology.

[17]  W. Schunck,et al.  Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids , 2010 .

[18]  L. Weinehall,et al.  The Västerbotten Intervention Programme: background, design and implications , 2010, Global health action.

[19]  P. Marik,et al.  Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review , 2009, Clinical cardiology.

[20]  D. Mozaffarian,et al.  Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention , 2009, Circulation.

[21]  K. Lunetta,et al.  Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .

[22]  M. Dorgan,et al.  Effect of fish oil on arrhythmias and mortality: systematic review , 2008, BMJ : British Medical Journal.

[23]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[24]  L. Arterburn,et al.  Distribution, interconversion, and dose response of n-3 fatty acids in humans. , 2006, The American journal of clinical nutrition.

[25]  M. K. Kim,et al.  Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. , 2005, American journal of epidemiology.

[26]  C. Meisinger,et al.  The MONICA Augsburg surveys--basis for prospective cohort studies. , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[27]  K. Reynolds,et al.  Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. , 2004, The American journal of clinical nutrition.

[28]  H. Worthington,et al.  Omega 3 fatty acids for prevention and treatment of cardiovascular disease. , 2004, The Cochrane database of systematic reviews.

[29]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[30]  D. Mozaffarian,et al.  The fish story: a diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death. , 2003, Circulation.

[31]  L. Rallidis,et al.  Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. , 2003, Atherosclerosis.

[32]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[33]  T. Pitcher,et al.  Towards sustainability in world fisheries , 2002, Nature.

[34]  C. Schindler,et al.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. , 2002, The American journal of medicine.

[35]  D. English,et al.  The Melbourne Collaborative Cohort Study. , 2002, IARC scientific publications.

[36]  S. Bandinelli,et al.  Changes in anthropometric measures in men and women across the life-span: findings from the inCHIANTI study , 2002, Sozial- und Präventivmedizin.

[37]  T. Hurst,et al.  Influence of dietary supplementation with long-chain n−3 or n−6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults , 2001, Lipids.

[38]  D O Stram,et al.  Singapore Chinese Health Study: Development, Validation, and Calibration of the Quantitative Food Frequency Questionnaire , 2001, Nutrition and cancer.

[39]  C. Hennekens,et al.  Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. , 2000, Annals of epidemiology.

[40]  T. Lakka,et al.  Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study , 1999, The Lancet.

[41]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[42]  G. Billman,et al.  Prevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs , 1999 .

[43]  B. Holub,et al.  Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. , 1998, Journal of lipid research.

[44]  M. Woodward,et al.  Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study , 1997, BMJ.

[45]  T. Raghunathan,et al.  Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. , 1995, JAMA.

[46]  P. McLennan,et al.  Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. , 1995, The Journal of nutrition.

[47]  J. Huttunen,et al.  EURAMIC Study: antioxidants, myocardial infarction and breast cancer. Design and main hypotheses. , 1993, European journal of clinical nutrition.

[48]  S. Greenland,et al.  Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. , 1992, American journal of epidemiology.

[49]  E. Rimm,et al.  Prospective study of alcohol consumption and risk of coronary disease in men , 1991, The Lancet.

[50]  J. Ordovás,et al.  Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[51]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[52]  D. Albanes,et al.  Dietary fat and risk of breast cancer. , 1990, The American journal of clinical nutrition.

[53]  Aric Invest.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[54]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[55]  H. Hedstrand.  [Results and observations from the Uppsala project]. , 1972, Lakartidningen.

[56]  S. Hashimoto,et al.  Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. , 1966, Journal of lipid research.

[57]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.